— Know what they know.
Not Investment Advice

TRVI NASDAQ

Trevi Therapeutics, Inc.
1W: -6.1% 1M: -4.3% 3M: +33.1% YTD: +19.1% 1Y: +118.9% 3Y: +451.0% 5Y: +587.4%
$14.13
-0.03 (-0.21%)
 
Weekly Expected Move ±6.3%
$12 $13 $14 $15 $16
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 45 · $2.0B mcap · 118M float · 1.29% daily turnover · Short 64% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-46M
Net Income
+3.7% YoY
$-32M
Free Cash Flow
+22.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-32.2%
ROA-30.0%
ROIC977.9%

Valuation

P/E-45.1
P/B12.0
EV/EBITDA-32.8

Leverage

Debt/Equity0.00
Current Ratio19.66
Interest Cov.0.0x

Quality Scores

Piotroski F4/9
Altman Z100.16
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms